Axcelis Technologies: Needham & Co maintains buy rating. Price target up to $140 from $100.

Baxter International: Stifel cut the target to $45 from $55. Maintains buy rating.

Eastman Chemical: Piper Sandler heightened the expectationto $96 from $86 maintaining neutral rating.

Expedia Group: Mizuho Securities raised the price target to $120 from $105. Maintains neutral rating.

First American Financial: Stephens raised the recommendation to overweight from equal-weight. PT set to $72.

Hilton Worldwide: Truist Securities uppepd the goal to $160 from $147. Maintains hold rating.

Lincoln National: Piper Sandler maintains neutral rating. Price target slightly up to $36 from $31.

Lyft: J.P. Morgan downgrades to neutral from overweight. PT down 7.5% to $15.

International Flavors & Fragrances: Barclays cut the target to $82 from $96. Maintains underweight rating.

Onto Innovation: Stifel raised the target to $97 from $85. Maintains buy rating.

AbbVie: SVB raised the recommendation to market perform from underperform. PT set to $153.

WEX: Mizuho Securities maintains buy rating. Price target upgrades to $220 from $200.